Abstract:Purpose In this study, we applied laser capture microdissection and a proteomic approach to identify novel nasopharyngeal carcinoma (NPC) biomarkers. Methods Proteins from pooled microdissected NPC and normal nasopharyngeal epithelial tissues (NNET) were separated by two-dimensional gel electrophoresis, and differential proteins were identified by mass spectrometry. Expression of the differential protein cytokeratin 18 in the above two tissues as well as 4 NPC cell lines was determined by Western blotting. Immunohistochemistry was also performed to detect the expression of cytokeratin 18 in 62 cases of primary NPC, 28 cases of NNET, and 20 cases of cervical lymph node metastases, and the correlation of its expression level with clinicopathologic features and clinical outcomes were evaluated. siRNA and in vitro cell invasion assay were used to check the correlation between the expression of cytokeratin 18 and invasive ability of NPC. Results Thirty-six differential proteins between the NPC and NNET were identified. The expression level of cytokeratin 18 in the two types of tissues was confirmed by Western blotting and related to differentiation degree and metastatic potential of the NPC cell lines. Significant cytokeratin 18 down-regulation was observed in NPC versus NNET ( P = 0.000), whereas significant cytokeratin 18 up-regulation was observed in lymph node metastasis versus primary NPC ( P = 0.001). In addition, cytokeratin 18 down-regulation was significantly correlated with poor histological differentiation ( P = 0.000), whereas cytokeratin 18 up-regulation was significantly correlated with advanced clinical stage ( P = 0.019), recurrence ( P = 0.000), and regional lymph node metastasis ( P = 0.001), and distant metastasis ( P = 0.000). And down-regulated cytokeratin 18 expression by siRNA significantly decreased in vitro invasive ability of 5-8F cells. Furthermore, survival curves showed that patients with cytokeratin 18 up-regulation had a poor prognosis ( P = 0.000). Univariate analysis (Cox’s proportional hazards model) showed that WHO histologic type ( P = 0.025), lymph node metastasis ( P = 0.007), distant metastasis ( P = 0.005), recurrence ( P = 0.000), and cytokeratin 18 ( P = 0.000) were significantly associated with the prognosis of NPC. Multivariate analysis confirmed that lymph node metastasis ( P = 0.012), distant metastasis ( P = 0.009), recurrence ( P = 0.006), and cytokeratin 18 ( P = 0.001) were independent prognostic indicators. Conclusions The data suggest that cytokeratin 18 is a potential biomarker for the differentiation and prognosis of NPC, and its dysregulation might play an important role in the pathogenesis of NPC.

Proteomic Analysis to Identify Cytokeratin 18 As a Novel Biomarker of Nasopharyngeal Carcinoma

Cytoplasmic p27 is a novel prognostic biomarker and oncogenic protein for nasopharyngeal carcinoma.

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Identification of nasopharyngeal carcinoma antigens that induce humoral immune response by proteomic analysis.

Novel prognostic biomarkers in nasopharyngeal carcinoma unveiled by mega-data bioinformatics analysis

A novel proteomic prognostic signature characterizes the immune landscape and predicts nasopharyngeal carcinoma prognosis

Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma

Functional analysis of the nasopharyngeal carcinoma primary tumor-associated gene interaction network

The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data

The prognostic significance of tyrosine-protein phosphatase nonreceptor type 12 expression in nasopharyngeal carcinoma

Identifying key genes and small molecule compounds for nasopharyngeal carcinoma by various bioinformatic analysis

Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma

Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma

CDK3 expression and its clinical significance in human nasopharyngeal carcinoma.

Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma

[Key Prediction Genes of Nasopharyngeal Carcinoma:Screening Based on Systematic Bioinformatics and Validation by Cell Experiments]

Serum CYFRA21-1 As an Effective Tumor Biomarker for Patients with Nasopharyngeal Carcinoma

Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis

Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival

Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.

Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis